Posted on April 23, 2008 by ecreese
Attendees awoke to the news this morning about GlaxoSmithKline’s announcement that it will pay millions — $720 million to be exact — for Sirtris Pharmaceuticals. This is the stuff biotech CEOs dream about. And it was the buzz at many breakfast tables at this morning’s workshop, “Antibiotics: Bad Bugs – Few Drugs.”
The BNVC meeting, of [...]
Filed under: national venture conference | Tagged: BIO, biotechnology, Biotechnology Industry Organization, national venture conference, venture funding | No Comments »
Posted on April 22, 2008 by ecreese
While the economy may not be as robust as it has in recent years, there certainly was no sign of that at today’s Opening Luncheon. Jim Greenwood, our President & CEO welcomed attendees to the inaugural BIO National Venture Conference and cited these impressive stats:
140 top-level (VP and higher) venture capitalists – including 4 international investors – [...]
Filed under: national venture conference | Tagged: BIO, biotechnology, Biotechnology Industry Organization, national venture conference, nvc, venture funding | No Comments »
Posted on April 22, 2008 by ecreese
The marathon may be over, but that doesn’t mean there isn’t plenty more activity going on here in Boston. We’re here in Cambridge, one of biotechnology’s “hot-spots” for the inaugural BIO National Venture Conference meeting up with some of the newest early stage and seed stage companies seeking venture funding. Stay tuned for more as the [...]
Filed under: national venture conference | Tagged: BIO, biotechnology, Biotechnology Industry Organization, bnvc, national venture conference, venture funding | No Comments »
Posted on March 12, 2008 by ecreese
I’m fascinated by priority review vouchers. The concept is a creative new mechanism that’s capturing a lot of people’s attention at the PGH conference. And how the vouchers came into being is even more fascinating. Basically, the vouchers are a means of encouraging R&D for conditions that, otherwise, would be largely ignored - you know, [...]
Filed under: Partnering for Global Health | Tagged: BIO, Partnership for Global Health, Biotechnology Industry Organization, PGH, BVGH, BIO Ventures for Global Health, Priority Review Vouchers, Sam Brownback, Brownback, Sherrod Brown | No Comments »
Posted on March 11, 2008 by ecreese
Every once in a while someone makes a statement that really resonates with you. At today’s luncheon, the topic was global health (of course!) and the challenges and opportunities for engaging in global health product development. Panelists included BIO’s Chairman of the Board, Joshua Boger, president and CEO of Vertex Pharmaceuticals; Una Ryan, CEO of [...]
Filed under: Partnering for Global Health | Tagged: Bill & Melinda Gates Foundation, Bill and Melinda Gates Foundation, BIO, BIO Ventures for Global Health, Biotechnology Industry Organization, BVGH, Gates Foundation, Global Health, Malaria, malaria vaccine, Partnership for Global Health, PGH | No Comments »
Posted on March 11, 2008 by ecreese
The question is what does the “e” stand for?
That was the subject of much discussion at the PGH Forum on this overcast morning in Reston, VA. The all-star panel discussion spent more than an hour talking passionately about malaria and what it will take to contain the disease.
For some, like the Bill & Melinda Gates [...]
Filed under: Partnering for Global Health | Tagged: BIO, Partnership for Global Health, Biotechnology Industry Organization, Malaria, Global Health, PGH, BVGH, BIO Ventures for Global Health, Gates Foundation, Bill and Melinda Gates Foundation, Bill & Melinda Gates Foundation, malaria vaccine | No Comments »
susanatbio
TKtraveler
nicoleatbio
ecreese
sourav123
Jennifer Miller
Darren Fast
christineross
arubenstein
patentbaristas
sdmimi
mikesgene
